Kalvista Pharmaceuticals (KALV) Q3 2023 Earnings

7DecConfirmed
Q4 2022
Q2 2023
Q2 2023
Q3 2023
-0.98
-0.9
-0.82
-0.74

Details

Expected EPS
-0.79
Actual EPS
-0.8
Surprise EPS
-0.01
Surprise Percent
+1.27%

Description

Kalvista Pharmaceuticals (KALV) has reported earnings of -0.8 per share for Q3 2023.

0 Comments

Share your thoughts